Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

The best way to beat persistent inflation is to invest in businesses unaffected by rising prices, like these four high-yield ...

Medicare changes will cut $1 billion from 2025 revenue, with Pfizer now responsible for 20% of catastrophic drug costs. Read ...

This event will provide resources and information to help create a healthier and more productive farming environment.

该药是一款新型凝血因子Xa抑制剂，迭代的是传统抗凝药物如华法林的市场。2012年获得FDA批准用于非瓣膜性心房颤动患者，以降低中风和血栓的风险。2014年，它被批准用于治疗深静脉血栓形成（DVT）和肺栓塞（PE）。现主要用于多种血栓栓塞性疾病的临床使 ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Uvax Bio, LLC has announced the appointment of Kevin O’Neill as Interim Chief Executive Officer (CEO), succeeding company co-founder Ji Li, Ph.D. The leadership transition comes as the ...

辉瑞还计划出售Haleon Plc 7.7%的股份，可能筹集31亿美元。与此同时，在RFK Jr澄清其立场并非反疫苗或反行业后，Moderna投资者信心上升。最后，Bernstein分析师选择Eli Lilly and Company作为2025年美国生物制药行业的首选，理由是对orforglipron的潜力及公司的领导地位持乐观态度。这些都是生物制药行业的最新发展。

Pfizer PFE reported fourth-quarter 2024 adjusted earnings per share of 63 cents, which beat the Zacks Consensus Estimate of 48 cents per share. The company had recorded earnings of 10 cents per share ...

On the flip side, vaccines Prevnar and Abrysvo underperformed expectations. Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 RSV vaccine Abrysvo specifically floundered ...